Bobak R. Azamian sold $1.2M of Tarsus Pharmaceuticals (TARS)

Executed Mar 18 2025, disclosed Mar 20 2025, 2 days later.

Value, as filed

$1.2M

24,216 sh across 3 lots

Executed

Mar 18 2025

the trade date, as filed

Disclosed

Mar 20 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Bobak R. Azamian President/CEO and Board Chair profile →

Bobak R. Azamian (President/CEO and Board Chair) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales, 1 filed past the two-business-day deadline), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $2.4M of TARS (34,603 sh across 3 lots, as filed), executed Mar 17.

The name

TARS

Tarsus Pharmaceuticals, Inc. TARS · Healthcare · 35 filings in 24 months ticker →

Healthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Bobak R. Azamian in TARS

TARSSALE Tarsus Pharmaceuticals, Inc. $906K
10,000 sh across 2 lots
Exec Sep 4
Filed Sep 9 · 4:14 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $801K
10,000 sh × $80.06
Exec Sep 2
Filed Sep 3 · 4:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $615K
10,000 sh across 2 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $2.4M
34,603 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $449K
5,443 sh × $82.41
Exec Dec 24 2025
Filed Dec 30 2025 · 5:30 PM ET † TARSSALE Tarsus Pharmaceuticals, Inc. $332K
6,000 sh × $55.37
Exec Sep 24 2025
Filed Sep 26 2025 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $300K
6,000 sh × $50.00
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $300K
6,000 sh × $50.00
Exec Mar 24 2025
Filed Mar 26 2025 · 5:30 PM ET